Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LSS | P48449 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6967400 | 0.91 | — | — | |
| SCHEMBL13745040 | 0.87 | KDM4E (0.32) | KDM4E | |
| SCHEMBL24654499 | 0.85 | CHRM2 (0.37) | CHRM2KDM4E | |
| SCHEMBL6961851 | 0.85 | CHRM2 (0.48) | CHRM2KDM4ELSS | |
| SCHEMBL25564635 | 0.83 | CHRM2 (0.52) | CHRM2MEN1KMT2ALSS | |
| SCHEMBL3323907 | 0.81 | HRH4 (0.40) | CHRM2KDM4E | |
| SCHEMBL21689392 | 0.81 | ADH1C (0.37) | KDM4ELSS | |
| SCHEMBL25921683 | 0.78 | KDM4E (0.32) | KDM4E | |
| SCHEMBL7857024 | 0.78 | PIK3CD (0.30) | — | |
| SCHEMBL8852258 | 0.78 | CHRM2 (0.32) | CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209511-A1 | Benzofuran Derivatives | KAWAGUCHI TAKAYUKI | 2009-08-20 | — | — | US | disclosed |
| US-20090209511-A1 | Benzofuran Derivatives | KAWAGUCHI TAKAYUKI | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209511-A1 | Benzofuran Derivatives | F12, F2, F3 | CHRM2 3900/4885MEN1 2864/4885KMT2A 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.